Literature DB >> 25528743

A new tool predicting survival after radiosurgery alone for one or two cerebral metastases from lung cancer.

Dirk Rades1, Stefan Huttenlocher, Liesa Dziggel, Mai Trong Khoa, Pham Van Thai, Dagmar Hornung, Steven E Schild.   

Abstract

Radiosurgery is frequently used for patients with few cerebral metastases. Decisions regarding personalized treatment should include the patient's survival prognosis. Prognostic tools should be available for estimating the remaining lifetime for each primary tumor and treatment. We designed such a tool for patients receiving radiosurgery alone for cerebral metastases from lung cancer. Ten variables were analyzed in 98 patients. On multivariate analysis, extra-cranial spread was significantly associated with worse survival (p < 0.001). A trend was observed for poorer performance status (p = 0.08) and greater diameter of cerebral lesions (p = 0.07). Points for the tool were derived from 12-month survival rates of these variables and added, resulting in sum scores of 10-16 points. Three groups were built, 10-12, 14-15, and 16 points with 12-month survival rates of 22, 52, and 79% (p < 0.001). This new tool enables physicians to estimate the survival of lung cancer patients with few cerebral metastases which should impact individualized treatment choices.

Entities:  

Mesh:

Year:  2014        PMID: 25528743     DOI: 10.1007/s00408-014-9676-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  15 in total

1.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.

Authors:  Paul W Sperduto; Brian Berkey; Laurie E Gaspar; Minesh Mehta; Walter Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-10       Impact factor: 7.038

2.  Radiosurgery for brain metastases: a score index for predicting prognosis.

Authors:  E Weltman; J V Salvajoli; R A Brandt; R de Morais Hanriot; F E Prisco; J C Cruz; S R de Oliveira Borges; D B Wajsbrot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-03-15       Impact factor: 7.038

3.  Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems.

Authors:  José Lorenzoni; Daniel Devriendt; Nicolas Massager; Phillippe David; Salvador Ruíz; Bruno Vanderlinden; Paul Van Houtte; Jacques Brotchi; Marc Levivier
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-09-01       Impact factor: 7.038

4.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.

Authors:  Paul W Sperduto; Samuel T Chao; Penny K Sneed; Xianghua Luo; John Suh; David Roberge; Amit Bhatt; Ashley W Jensen; Paul D Brown; Helen Shih; John Kirkpatrick; Amanda Schwer; Laurie E Gaspar; John B Fiveash; Veronica Chiang; Jonathan Knisely; Christina Maria Sperduto; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-11-26       Impact factor: 7.038

5.  The first survival score for patients with brain metastases from small cell lung cancer (SCLC).

Authors:  Dirk Rades; Liesa Dziggel; Barbara Segedin; Irena Oblak; Viorica Nagy; Andreea Marita; Steven E Schild
Journal:  Clin Neurol Neurosurg       Date:  2013-07-18       Impact factor: 1.876

6.  A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.

Authors:  Dirk Rades; Juergen Dunst; Steven E Schild
Journal:  Strahlenther Onkol       Date:  2008-05       Impact factor: 3.621

7.  Histology as a potential clinical predictor of outcome in advanced non-small-cell lung cancer treated with vinorelbine and mitomycin combination chemotherapy.

Authors:  Thomas Wibmer; Thierry Berghmans; Cornelia Kropf-Sanchen; Jean-Jacques Lafitte; Stefan Rüdiger; Marianne Paesmans; Ioanna Blanta; Arnaud Scherpereel; Kathrin M Stoiber; Wolfgang Rottbauer; Jean-Paul Sculier; Christian Schumann
Journal:  Lung       Date:  2013-04-07       Impact factor: 2.584

8.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

9.  Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels.

Authors:  Dirk Rades; Dagmar Hornung; Oliver Blanck; Kristina Martens; Mai Trong Khoa; Ngo Thuy Trang; Michael Hüppe; Patrick Terheyden; Jan Gliemroth; Steven E Schild
Journal:  Strahlenther Onkol       Date:  2014-03-25       Impact factor: 3.621

10.  Treatment outcomes in elderly with advanced-stage non-small cell lung cancer.

Authors:  Terence Chi-Chun Tam; James Chung-Man Ho; Matthew King-Yan Wong; Wai-Mui Wong; Julie Kwan-Ling Wang; Jamie Chung-Mei Lam; Macy Mei-Sze Lui; Wah-Kit Lam; Mary Sau-Man Ip; David Chi-Leung Lam
Journal:  Lung       Date:  2013-08-09       Impact factor: 2.584

View more
  5 in total

1.  A Survival Score Based on Symptoms and Performance Status for Patients with High-grade Gliomas Receiving Radiochemotherapy.

Authors:  Pham Cam Phuong; LE Viet Nam; Steven E Schild; Dirk Rades; Mai Trong Khoa
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

2.  A New Score for Estimating Survival After Definitive Radiochemotherapy of Limited Disease Small Cell Lung Cancers.

Authors:  Dirk Rades; Lukas Kaesmann; Stefan Janssen; Steven E Schild
Journal:  Lung       Date:  2016-05-02       Impact factor: 2.584

3.  An easy-to-use scoring system to estimate the survival of patients irradiated for bone metastases from lung cancer.

Authors:  Dirk Rades; Rapha Haus; Stefan Janssen; Steven E Schild
Journal:  Transl Lung Cancer Res       Date:  2020-08

4.  Development of a multivariable prediction model to estimate the remaining lifespan of elderly patients with cerebral metastases from small-cell lung cancer.

Authors:  Dirk Rades; Trang Nguyen; Stefan Janssen; Steven E Schild
Journal:  Transl Lung Cancer Res       Date:  2020-08

5.  Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort: A retrospective study of multiple institutions.

Authors:  Tingyou Zhang; Yu Zhang; Lin Zhou; Shanshan Deng; Meijuan Huang; Yuncong Liu; Yongmei Liu; Youlin Gong; Jiang Zhu; Jianxin Xue; Yuju Bai; Hu Ma; Yan Zhang; Min Yu; Yanying Li; Yongsheng Wang; Bingwen Zou; Xiaojuan Zhou; Weigang Xiu; Feifei Na; Yong Xu; Feng Peng; Jin Wang; You Lu
Journal:  Cancer Med       Date:  2020-10-07       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.